• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力治疗后小鼠肿瘤灌注的变化。

Changes in perfusion of mouse tumours after photodynamic therapy.

作者信息

van Geel I P, Oppelaar H, Oussoren Y G, Stewart F A

机构信息

Division of Experimental Therapy (H6), The Netherlands Cancer Institute, Amsterdam.

出版信息

Int J Cancer. 1994 Jan 15;56(2):224-8. doi: 10.1002/ijc.2910560214.

DOI:10.1002/ijc.2910560214
PMID:8314306
Abstract

The influence of photodynamic therapy (PDT) on vascular perfusion was investigated in 2 s.c. mouse tumours, a radiation-induced fibrosarcoma (RIF I) and a squamous-cell carcinoma (SCCVII). The 86Rb extraction technique was used to measure changes in perfusion relative to cardiac output at various intervals after interstitial PDT. Control groups showed that vascular perfusion in the RIF I tumours decreased with increasing tumour size. For both tumours, of constant size, vascular perfusion decreased to less than 10% of control values within 5 min after high PDT doses. Significant decreases in vascular perfusion were also seen after lower, sub-curative doses. Thereafter there was slow recovery towards control levels. Photofrin given at shorter intervals before illumination generally resulted in even larger decreases in tumour perfusion, and slower recovery. Comparison of tumour perfusion measurements after PDT with tumour response revealed an inverse correlation with tumour growth delay both for the RIF I and for the SCCVII tumours. PDT with sub-curative light doses appears to decrease vascular perfusion in the RIF I and SCCVII for a period of at least 24 hr. The most severe reductions in tumour blood flow were associated with the longest regrowth delays, indicating a major role of vascular damage in tumour response to PDT.

摘要

在两种皮下小鼠肿瘤(一种辐射诱导的纤维肉瘤(RIF I)和一种鳞状细胞癌(SCCVII))中研究了光动力疗法(PDT)对血管灌注的影响。采用⁸⁶Rb提取技术来测量间质PDT后不同时间间隔相对于心输出量的灌注变化。对照组显示,RIF I肿瘤中的血管灌注随着肿瘤大小的增加而降低。对于两种大小恒定的肿瘤,在高剂量PDT后5分钟内,血管灌注降至对照值的10%以下。较低的亚治愈剂量后也观察到血管灌注显著降低。此后,血管灌注缓慢恢复至对照水平。在光照前较短间隔给予光敏剂通常会导致肿瘤灌注的更大降低和更慢的恢复。PDT后肿瘤灌注测量结果与肿瘤反应的比较显示,RIF I和SCCVII肿瘤的肿瘤生长延迟均呈负相关。亚治愈光剂量的PDT似乎在至少24小时内降低了RIF I和SCCVII中的血管灌注。肿瘤血流的最严重减少与最长的再生长延迟相关,表明血管损伤在肿瘤对PDT的反应中起主要作用。

相似文献

1
Changes in perfusion of mouse tumours after photodynamic therapy.光动力治疗后小鼠肿瘤灌注的变化。
Int J Cancer. 1994 Jan 15;56(2):224-8. doi: 10.1002/ijc.2910560214.
2
Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.用肿瘤坏死因子-α诱导药物5,6-二甲基呫吨酮-4-乙酸进行治疗可增强RIF-1小鼠肿瘤光动力疗法的抗肿瘤活性。
Cancer Res. 2003 Nov 15;63(22):7584-90.
3
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.优化光动力疗法的机制:第二代光敏剂与丝裂霉素C联合使用
Br J Cancer. 1995 Aug;72(2):344-50. doi: 10.1038/bjc.1995.336.
4
Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply.肿瘤中光敏剂的细胞水平:与血液供应接近程度的作用。
Br J Cancer. 1994 Oct;70(4):604-10. doi: 10.1038/bjc.1994.358.
5
Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.光动力治疗后RIF-1肿瘤中的血管灌注和缺氧区域
Br J Cancer. 1996 Feb;73(3):288-93. doi: 10.1038/bjc.1996.51.
6
A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy.表达绿色荧光蛋白的小鼠肿瘤可通过光动力疗法治愈,而其野生型对应物则不能。
Br J Cancer. 2006 Feb 13;94(3):391-7. doi: 10.1038/sj.bjc.6602953.
7
The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.血清α-N-乙酰半乳糖苷酶检测在评估肿瘤对放疗和光动力治疗反应中的价值。
Br J Cancer. 1998 Mar;77(6):1009-14. doi: 10.1038/bjc.1998.166.
8
Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer.辐照度控制实验性肿瘤中的光动力疗效和组织加热:对局部晚期癌症的间质 PDT 的影响。
Br J Cancer. 2018 Nov;119(10):1191-1199. doi: 10.1038/s41416-018-0210-y. Epub 2018 Oct 24.
9
Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy.肿瘤组织中一氧化氮的产生:对光动力疗法反应的影响。
Br J Cancer. 2000 Jun;82(11):1835-43. doi: 10.1054/bjoc.2000.1157.
10
In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.对体外光卟啉介导的光动力疗法耐药的辐射诱导纤维肉瘤细胞对光卟啉介导的光动力疗法的体内抗性
J Photochem Photobiol B. 1999 Apr;49(2-3):136-41. doi: 10.1016/s1011-1344(99)00047-0.

引用本文的文献

1
Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.氨基酮戊酸光动力疗法联合局部应用血管破坏剂vadimezan 可增强抗肿瘤反应。
Photochem Photobiol. 2011 Jul-Aug;87(4):910-9. doi: 10.1111/j.1751-1097.2011.00943.x. Epub 2011 Jun 13.
2
Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.光动力疗法中的内隐和外显剂量学:一种新范例。
Lasers Med Sci. 1997 Oct;12(3):182-99. doi: 10.1007/BF02765099.
3
Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours.
光动力疗法治疗的小鼠肿瘤中的缺血再灌注损伤
Br J Cancer. 2003 Mar 10;88(5):760-6. doi: 10.1038/sj.bjc.6600792.
4
Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy.肿瘤组织中一氧化氮的产生:对光动力疗法反应的影响。
Br J Cancer. 2000 Jun;82(11):1835-43. doi: 10.1054/bjoc.2000.1157.
5
Current concepts in gastrointestinal photodynamic therapy.胃肠道光动力治疗的当前概念
Ann Surg. 1999 Jul;230(1):12-23. doi: 10.1097/00000658-199907000-00003.
6
Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.体内光动力治疗期间及之后肿瘤氧合作用的降低:光通量率的影响
Br J Cancer. 1998 May;77(9):1386-94. doi: 10.1038/bjc.1998.231.
7
Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.血卟啉衍生物对人结肠癌细胞经5-氨基乙酰丙酸致敏后原卟啉IX合成及光动力效应的影响
Br J Cancer. 1997;76(7):878-83. doi: 10.1038/bjc.1997.478.
8
Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.大鼠CC531腺癌的腹腔内光动力疗法
Br J Cancer. 1996 Jun;73(11):1387-92. doi: 10.1038/bjc.1996.263.
9
Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.光动力治疗后RIF-1肿瘤中的血管灌注和缺氧区域
Br J Cancer. 1996 Feb;73(3):288-93. doi: 10.1038/bjc.1996.51.
10
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.优化光动力疗法的机制:第二代光敏剂与丝裂霉素C联合使用
Br J Cancer. 1995 Aug;72(2):344-50. doi: 10.1038/bjc.1995.336.